|Equation||(# participants) x (% participants who receive treatment solely because of the program) x (# QALY increase) x ($ QALY)|
|Explanation||This metric estimates the impact of post-traumatic stress disorder or depression treatment on lifetime health, estimated in terms of quality-adjusted life years (QALY). This metric should only be used for programs using best-practice treatments. This metric should be used in conjunction with HEA023.|
Number of participants: Reported by program.
Percentage of participants receiving treatment solely because of program: [54%]. This is estimated by Constellation Fund staff based on data from SAMHSA (2017) which shows that 46% of individuals under 200% of the federal poverty level with any mental illness receive mental health care. Thus, we estimate that about 54% of participants would have not received treatment in the absence of the program.
QALY increase: [0.15]. This is the value of the relief symptoms of PTSD or depression due to best practice therapeutic or pharmacological care (Revicki et al., 2005; Rost, Pyne, Dickinson & LoSasso, 2005). Note that this QALY value already accounts for the probabilities of treatment response.
$ value per QALY: [$50,000]
Benefits are then discounted to present value based on the average age of participation to life expectancy.
|References||Johar, M. & Truong, J. (2014). Direct and indirect effect of depression in adolescence on adult wages. Applied Economics, 46(36), 4431–4444.|
Revicki, D., Siddique, J., Frank, L., Chung, J., Green, B., Krupnick, J., Prasad, M. & Miranda, J. (2005). Cost- effectiveness of evidence-based pharmacotherapy or cognitive behavioral therapy compared with community referral for major depression in predominantly low-income minority women. Archives of General Psychiatry, 62(8), 868-875.
Rost, K., Pyne, J., Dickinson, L. M. & LoSasso, A. T. (2005). Cost-effectiveness of enhancing primary care depression management on an ongoing basis. Annals of Family Medicine, 3(1), 7-14.
Substance Abuse and Mental Health Services Administration (SAMHSA). (2017). Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from: https://www.samhsa.gov/data/